Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer

Although there are a lot of chemical drugs to treat breast cancer, increasing drug resistance of cancer cells has strongly hindered the effectiveness of chemotherapy. ATP-binding cassette transporters represented by P-glycoprotein (P-gp), multidrug resistance associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) play an important role in drug resistance. This study aims to investigate the effect of 7-O-geranylquercetin (GQ) combining microRNA-451(miR-451) on reversing drug resistance of breast cancer and reveal the mechanism related to P-gp. Real-time RT-PCR and western blot assays showed that miR-326, miR-328, miR-451 and miR-155 inhibitor down-regulated the expression of genes MRP1, BCRP, MDR1 and the corresponding proteins MRP1, BCRP, P-gp, respectively. Cell counting kit-8 (CCK-8) assay indicated that these miRNAs reversed the resistance of MCF-7/ADR cells to Adriamycin (ADR), and miR-451 showed the greatest reversal effect. Combination of GQ and miR-451 enhanced the inhibitory effects of ADR on the proliferation and migration of MCF-7/ADR cells, and attenuated the expression of MDR1 and P-gp in MCF-7/ADR cells. A xenograft tumor model was used to show that GQ and miR-451 amplified the antitumor effect of ADR in nude mice, while western blot and immunohistochemical assays revealed the decreased expression of P-gp in tumor tissues. These results suggest that GQ and miR-451 have synergistic effect on reversing drug resistance through reducing the expression of MDR1 and P-gp in breast cancer MCF-7/ADR cells.

[1]  Ansar Karimian,et al.  miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells. , 2020, European journal of pharmacology.

[2]  Tian Tian,et al.  Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer , 2020, Journal of Nanobiotechnology.

[3]  Shubiao Zhang,et al.  Liposome-based co-delivery of 7-O-geranyl-quercetin and IGF-1R siRNA for the synergistic treatment of non-small cell lung cancer , 2019, Journal of Drug Delivery Science and Technology.

[4]  Shubiao Zhang,et al.  7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. , 2019, Life sciences.

[5]  Shubiao Zhang,et al.  Toxicological exploration of peptide-based cationic liposomes in siRNA delivery. , 2019, Colloids and surfaces. B, Biointerfaces.

[6]  Shubiao Zhang,et al.  Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer. , 2019, Life sciences.

[7]  Wensheng Yan,et al.  A PolH transcript with a short 3'UTR enhances PolH expression and mediates cisplatin resistance. , 2019, Cancer research.

[8]  V. Tomar,et al.  A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer , 2019, Molecular and Cellular Biology.

[9]  S. Ambudkar,et al.  ABC Transporter-Mediated Multidrug-Resistant Cancer. , 2019, Advances in experimental medicine and biology.

[10]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[11]  M. Falasca,et al.  ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance , 2017, International journal of molecular sciences.

[12]  Xiaodong Ma,et al.  7‐O‐geranylquercetin‐induced autophagy contributes to apoptosis via ROS generation in human non‐small cell lung cancer cells , 2017, Life sciences.

[13]  Changyuan Wang,et al.  7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  S. Khan,et al.  miRNA nanotherapeutics for cancer. , 2017, Drug discovery today.

[15]  Yan-ru Ge,et al.  Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells , 2016, International journal of nanomedicine.

[16]  Wei Zhang,et al.  Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs , 2016, International journal of nanomedicine.

[17]  P. Gao,et al.  Suppression of SPIN1‐mediated PI3K–Akt pathway by miR‐489 increases chemosensitivity in breast cancer , 2016, The Journal of pathology.

[18]  R. Ma,et al.  Understanding the CREB1-miRNA feedback loop in human malignancies , 2016, Tumor Biology.

[19]  Lixia Lv,et al.  Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells. , 2016, Oncology letters.

[20]  N. Samadi,et al.  Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells , 2016, Molecular Biology Reports.

[21]  Jiao Qu,et al.  Synthesis, Characterization and Cytotoxicity of Alkylated Quercetin Derivatives , 2016, Iranian journal of pharmaceutical research : IJPR.

[22]  Xiaodong Ma,et al.  O-Alkylated derivatives of quercetin induce apoptosis of MCF-7 cells via a caspase-independent mitochondrial pathway. , 2015, Chemico-biological interactions.

[23]  A. Zhang,et al.  ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy. , 2015, Current drug targets.

[24]  D. Halagowder,et al.  Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells , 2015, PloS one.

[25]  M. Bekaert,et al.  A Survey of the ATP-Binding Cassette (ABC) Gene Superfamily in the Salmon Louse (Lepeophtheirus salmonis) , 2015, PloS one.

[26]  Ran Ma,et al.  High expression of cAMP responsive element binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer , 2015, Oncotarget.

[27]  Y. Zhang,et al.  Tri-peptide cationic lipids for gene delivery. , 2015, Journal of materials chemistry. B.

[28]  Z. Kozovska,et al.  Colon cancer: cancer stem cells markers, drug resistance and treatment. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  Yi Tie,et al.  MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration. , 2014, Oncology reports.

[30]  P. Gao,et al.  Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour , 2014, PloS one.

[31]  Liang-Nian Ji,et al.  Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. , 2012, Biomaterials.

[32]  J. Sun,et al.  EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers , 2011, Nature Medicine.

[33]  B. Jiang,et al.  miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP , 2012, Cancer Chemotherapy and Pharmacology.

[34]  E. Bandrés,et al.  MicroRNA‐451 Is Involved in the Self‐renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells , 2011, Stem cells.

[35]  K. Kang,et al.  Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin , 2011, Archives of pharmacal research.

[36]  E. Cooper,et al.  Quercetin and Cancer Chemoprevention , 2011, Evidence-based complementary and alternative medicine : eCAM.

[37]  Xi Chen,et al.  Role of microRNA in anticancer drug resistance , 2010, International journal of cancer.

[38]  Hongwei Zhang,et al.  Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma , 2010, Digestive Diseases and Sciences.

[39]  C. Rumi,et al.  Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target , 2004, Cancer Chemotherapy and Pharmacology.